{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T19:47:24Z","timestamp":1720640844843},"reference-count":16,"publisher":"Oxford University Press (OUP)","issue":"S3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":7548,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Stem Cells"],"published-print":{"date-parts":[[1995]]},"DOI":"10.1002\/stem.5530130707","type":"journal-article","created":{"date-parts":[[2009,6,12]],"date-time":"2009-06-12T16:46:19Z","timestamp":1244825179000},"page":"36-41","source":"Crossref","is-referenced-by-count":0,"special_numbering":"supplement S3","title":["Sequential high&hyphen;dose treatment with peripheral blood progenitor cell transplantation in patients with multiple myeloma"],"prefix":"10.1093","volume":"13","author":[{"given":"Hartmut","family":"Goldschmidt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ute","family":"Hegenbart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"Moos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Eugenhart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainer","family":"Haas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Werner","family":"Hunstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Wannenmacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"10.1002\/stem.5530130707-BIB1","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1056\/NEJM199402173300709","article-title":"The treatment of multiple myeloma","volume":"330","author":"Alexanian","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1002\/stem.5530130707-BIB2","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S0140-6736(83)90739-0","article-title":"High dose intravenous melphalan for plasma cell leukemia and myeloma","volume":"2","author":"McElwain","year":"1983","journal-title":"Lancet"},{"key":"10.1002\/stem.5530130707-BIB3","first-page":"181a","article-title":"GM‐CSF instead of autologous stem cell transplantation after high dose melphalan (HDM) in multiple myeloma (MM)","volume":"84","author":"Harrousseau","year":"1994","journal-title":"Blood"},{"key":"10.1002\/stem.5530130707-BIB4","first-page":"89","article-title":"Hemopoietic stem cell transplants for multiple myeloma","volume":"8","author":"Jagannath","year":"1994","journal-title":"Oncology"},{"key":"10.1002\/stem.5530130707-BIB5","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1365-2141.1994.tb04985.x","article-title":"Molecular detection of clonally rearranged cells in peripheral blood progenitor cell harvests from multiple myeloma patients","volume":"88","author":"Bird","year":"1994","journal-title":"Br J Hematol"},{"key":"10.1002\/stem.5530130707-BIB6","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U","article-title":"A clinical staging system for multiple myeloma","volume":"36","author":"Durie","year":"1975","journal-title":"Cancer"},{"key":"10.1002\/stem.5530130707-BIB7","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1182\/blood.V83.12.3787.3787","article-title":"Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma","volume":"83","author":"Haas","year":"1994","journal-title":"Blood"},{"key":"10.1002\/stem.5530130707-BIB8","volume-title":"WHO Handbook for Reporting Results of Cancer Treatment","year":"1979","unstructured":"WHO Handbook for Reporting Results of Cancer Treatment. Geneva: WHO Offset Publications, 1979."},{"key":"10.1002\/stem.5530130707-BIB9","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1182\/blood.V82.7.2005.2005","article-title":"High‐dose chemoradiotherapy and autologous blood stem cell transplantation in multiple myeloma: results of a phase II trial involving 63 patients","volume":"82","author":"Fermand","year":"1993","journal-title":"Blood"},{"key":"10.1002\/stem.5530130707-BIB10","first-page":"11","article-title":"Factors affecting blood stem cell collections following high‐dose cyclophosphamide mobilization in lymphoma, myeloma and solid tumors","volume":"9","author":"Kotasek","year":"1992","journal-title":"Bone Marrow Transplant"},{"key":"10.1002\/stem.5530130707-BIB11","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1182\/blood.V85.2.588.588","article-title":"Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients","volume":"85","author":"Tricot","year":"1995","journal-title":"Blood"},{"key":"10.1002\/stem.5530130707-BIB12","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1182\/blood.V85.11.3077.bloodjournal85113077","article-title":"Autologous stem cell transplantation after first remission induction treatment in multiple myeloma: a report of the French Registry on autologous transplantation in multiple myeloma","volume":"85","author":"Harrousseau","year":"1995","journal-title":"Blood"},{"key":"10.1002\/stem.5530130707-BIB13","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1182\/blood.V84.3.950.950","article-title":"High‐dose therapy for refractory multiple myeloma: improved prognosis with better supportive care and double transplants","volume":"84","author":"Vesole","year":"1994","journal-title":"Blood"},{"key":"10.1002\/stem.5530130707-BIB14","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1182\/blood.V84.10.3283.3283","article-title":"The hematopoietic stem cell antigen, CD34, is not expressed on the malignant cells in multiple myeloma","volume":"84","author":"Vescio","year":"1994","journal-title":"Blood"},{"key":"10.1002\/stem.5530130707-BIB15","unstructured":"Pico JL. A randomized multicentric phase III trial to evaluate hematological recovery and tumor cell contamination after CD34+ selection of peripheral blood progenitor cells with the CEPRATE SC in patients with multiple myeloma. EBMT Study, CellPro Europe Protocol EU 0081‐002 1995."},{"key":"10.1002\/stem.5530130707-BIB16","first-page":"S12a","article-title":"High dose therapy in multiple myeloma: a prospective randomized study of the “Intergroup Francais Du Myelome” (IFM)","volume":"15","author":"Attal","year":"1995","journal-title":"Bone Marrow Transplant"}],"container-title":["Stem Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fstem.5530130707","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/stem.5530130707\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T03:08:27Z","timestamp":1642561707000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/stmcls\/article\/13\/S3\/36-41\/6390035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995]]},"references-count":16,"journal-issue":{"issue":"S3","published-print":{"date-parts":[[1995]]}},"URL":"https:\/\/doi.org\/10.1002\/stem.5530130707","relation":{},"ISSN":["1066-5099","1549-4918"],"issn-type":[{"value":"1066-5099","type":"print"},{"value":"1549-4918","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995]]}}}